136 related articles for article (PubMed ID: 35039565)
1. Methylation statuses of NCOR2, PARK2, and ZSCAN12 signify densities of tumor-infiltrating lymphocytes in gastric carcinoma.
Wen X; Jin HY; Li M; Kim Y; Cho NY; Kwak Y; Bae JM; Lee HS; Kang GH
Sci Rep; 2022 Jan; 12(1):862. PubMed ID: 35039565
[TBL] [Abstract][Full Text] [Related]
2. Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
Kim Y; Rhee YY; Wen X; Cho NY; Bae JM; Kim WH; Kang GH
Gastric Cancer; 2020 May; 23(3):464-472. PubMed ID: 31691036
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
[TBL] [Abstract][Full Text] [Related]
5. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer.
Zou Q; Wang X; Ren D; Hu B; Tang G; Zhang Y; Huang M; Pai RK; Buchanan DD; Win AK; Newcomb PA; Grady WM; Yu H; Luo Y
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34548385
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
8. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
[TBL] [Abstract][Full Text] [Related]
9. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
10. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
[TBL] [Abstract][Full Text] [Related]
12. Density and location of CD3
Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of MHC class II-associated invariant chain expression in human gastric carcinoma.
Tamori Y; Tan X; Nakagawa K; Takai E; Akagi J; Kageshita T; Egami H; Ogawa M
Oncol Rep; 2005 Oct; 14(4):873-7. PubMed ID: 16142345
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis.
Lee JS; Won HS; Sun S; Hong JH; Ko YH
Medicine (Baltimore); 2018 Aug; 97(32):e11769. PubMed ID: 30095632
[TBL] [Abstract][Full Text] [Related]
16. Low PD-1 Expression in Cytotoxic CD8
Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
[No Abstract] [Full Text] [Related]
17. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
Li J; Wang J; Chen R; Bai Y; Lu X
Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
[TBL] [Abstract][Full Text] [Related]
19. CD3-zetachain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Higashi H; Iwashige H; Aridome K; Hokita S; Aikou T
Cancer; 2002 Mar; 94(5):1437-42. PubMed ID: 11920499
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer.
Lee HE; Chae SW; Lee YJ; Kim MA; Lee HS; Lee BL; Kim WH
Br J Cancer; 2008 Nov; 99(10):1704-11. PubMed ID: 18941457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]